Angela Gall

Royal National Orthopaedic Hospital

Papers

1

Total Citations

98

H-Index

1

About

Dr. Angela Gall is a leading clinician-researcher in spinal cord injury (SCI) rehabilitation, with a primary focus on restoring mobility and functional independence through advanced assistive technologies. Her seminal work, the RAPPER II trial, investigates the feasibility and safety of the REX self-stabilizing robotic exoskeleton for individuals with SCI who are obligatory wheelchair users. This landmark study, which has garnered 98 citations, demonstrated that patients could successfully transfer into and operate the device, opening new avenues for upright ambulation and functional exercise programs. Dr. Gall’s research directly addresses the critical gap between laboratory-based robotics and real-world clinical application, emphasizing patient safety, acceptability, and practical outcomes. Her contributions are pivotal in shaping evidence-based protocols for robotic rehabilitation, offering hope for improved cardiovascular health, bone density, and psychological well-being in the SCI community. By rigorously evaluating cutting-edge technologies, Dr. Gall is not only advancing the field of neurorehabilitation but also empowering patients with spinal cord injuries to reclaim a level of mobility previously thought unattainable.

Research Focus

Key Achievements

1
H-Index
1
Papers
98
Total Citations
98
Avg Citations/Paper
🏆 Most Cited Paper
Results of the first interim analysis of the RAPPER II trial in patients with spinal cord injury: ambulation and functional exercise programs in the REX powered walking aid
98 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Royal National Orthopaedic Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago